These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

417 related items for PubMed ID: 30174113

  • 21. Hepatopulmonary Syndrome and Portopulmonary Hypertension: Management in Liver Transplantation in the Horizon 2020.
    Sendra C, Carballo-Rubio V, Sousa JM.
    Transplant Proc; 2020 Jun; 52(5):1503-1506. PubMed ID: 32278579
    [Abstract] [Full Text] [Related]

  • 22. Portopulmonary Hypertension and Liver Transplant: Recent Review of the Literature.
    Cosarderelioglu C, Cosar AM, Gurakar M, Pustavoitau A, Russell SD, Dagher NN, Gurakar A.
    Exp Clin Transplant; 2016 Apr; 14(2):113-20. PubMed ID: 27015528
    [Abstract] [Full Text] [Related]

  • 23. Pulmonary Complications of Portal Hypertension.
    Cartin-Ceba R, Krowka MJ.
    Clin Liver Dis; 2019 Nov; 23(4):683-711. PubMed ID: 31563218
    [Abstract] [Full Text] [Related]

  • 24. A study of hepatopulmonary syndrome among patients of cirrhosis of liver and portal hypertension.
    Hira HS, Kumar J, Tyagi SK, Jain SK.
    Indian J Chest Dis Allied Sci; 2003 Nov; 45(3):165-71. PubMed ID: 12866633
    [Abstract] [Full Text] [Related]

  • 25. Portopulmonary Hypertension: Management and Liver Transplantation Evaluation.
    DuBrock HM.
    Chest; 2023 Jul; 164(1):206-214. PubMed ID: 36649754
    [Abstract] [Full Text] [Related]

  • 26. [Pulmonary hypertension in liver diseases].
    Savale L, Sattler C, Sitbon O.
    Presse Med; 2014 Sep; 43(9):970-80. PubMed ID: 25148949
    [Abstract] [Full Text] [Related]

  • 27. Pulmonary Complications of Portal Hypertension.
    Bommena S, Fallon MB.
    Clin Liver Dis; 2024 Aug; 28(3):467-482. PubMed ID: 38945638
    [Abstract] [Full Text] [Related]

  • 28. [Pulmonary complications of hepatic cirrhosis: portopulmonary hypertension and hepatopulmonary syndrome. The paradox of pulmonary vasoconstriction and vasodilation].
    Chávez-Tapia NC, Uribe M, López E.
    Gac Med Mex; 2007 Aug; 143(4):333-9. PubMed ID: 17969842
    [Abstract] [Full Text] [Related]

  • 29. Intrapulmonary vascular dilatations are common in portopulmonary hypertension and may be associated with decreased survival.
    Fussner LA, Iyer VN, Cartin-Ceba R, Lin G, Watt KD, Krowka MJ.
    Liver Transpl; 2015 Nov; 21(11):1355-64. PubMed ID: 26077312
    [Abstract] [Full Text] [Related]

  • 30. Hepatopulmonary syndrome and portopulmonary hypertension: implications for liver transplantation.
    Krowka MJ.
    Clin Chest Med; 2005 Dec; 26(4):587-97, vi. PubMed ID: 16263398
    [Abstract] [Full Text] [Related]

  • 31. [Porto-pulmonary hypertension].
    Chabot F, Gomez E, Boyer L, Kheir A, Le Pavec J, Sitbon O, Herve P.
    Rev Mal Respir; 2006 Dec; 23(6):629-41. PubMed ID: 17202968
    [Abstract] [Full Text] [Related]

  • 32. Portopulmonary hypertension.
    Krowka MJ.
    Semin Respir Crit Care Med; 2012 Feb; 33(1):17-25. PubMed ID: 22447257
    [Abstract] [Full Text] [Related]

  • 33. Hepatopulmonary syndrome and portopulmonary hypertension: what's new?
    Colle I, Van Steenkiste C, Geerts A, Van Vlierberghe H.
    Acta Gastroenterol Belg; 2007 Feb; 70(2):203-9. PubMed ID: 17715635
    [Abstract] [Full Text] [Related]

  • 34. Liver transplantation in high-risk patients: hepatopulmonary syndrome and portopulmonary hypertension.
    Martínez-Palli G, Taurà P, Balust J, Beltrán J, Zavala E, Garcia-Valdecasas JC.
    Transplant Proc; 2005 Nov; 37(9):3861-4. PubMed ID: 16386564
    [Abstract] [Full Text] [Related]

  • 35. Hepatopulmonary Syndrome and Portopulmonary Hypertension in Children: Recent Advances in Diagnosis and Management.
    Lee WS, Wong SY, Ivy DD, Sokol RJ.
    J Pediatr; 2018 May; 196():14-21.e1. PubMed ID: 29514741
    [No Abstract] [Full Text] [Related]

  • 36. Hepatopulmonary syndrome and portopulmonary hypertension: recent knowledge in pathogenesis and overview of clinical assessment.
    Raevens S, Geerts A, Van Steenkiste C, Verhelst X, Van Vlierberghe H, Colle I.
    Liver Int; 2015 Jun; 35(6):1646-60. PubMed ID: 25627425
    [Abstract] [Full Text] [Related]

  • 37. [Analysis of clinical features and targeted drug therapy of portopulmonary hypertension].
    Yang SQ, Yang YH, Kuang TG, Liu L, Gong JN, Ding Y, He JG.
    Zhonghua Yi Xue Za Zhi; 2019 Sep 24; 99(36):2806-2810. PubMed ID: 31550806
    [Abstract] [Full Text] [Related]

  • 38. Portopulmonary Hypertension in Liver Disease Presenting in Childhood.
    Ecochard-Dugelay E, Lambert V, Schleich JM, Duché M, Jacquemin E, Bernard O.
    J Pediatr Gastroenterol Nutr; 2015 Sep 24; 61(3):346-54. PubMed ID: 25885880
    [Abstract] [Full Text] [Related]

  • 39. Pulmonary complications in chronic liver disease.
    Machicao VI, Balakrishnan M, Fallon MB.
    Hepatology; 2014 Apr 24; 59(4):1627-37. PubMed ID: 24089295
    [Abstract] [Full Text] [Related]

  • 40. Hepatopulmonary syndrome and portopulmonary hypertension.
    Restrepo R, Singer EF, Baram M, Restrepo R, Singer EF, Baram M.
    Hosp Pract (1995); 2013 Apr 24; 41(2):62-71. PubMed ID: 23680738
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.